ZMIZ1 and amyloidosis: Furthermore, using two- and three-way interaction analysis we identified a region-specific synergistic interaction between α-synuclein and tau pathology, but not with amyloid pathology, in driving pS65-Ub levels in the amygdala, and nominated ZMIZ1 rs6480922 as a potential genetic driver in this pathological interplay.